Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated to v3.6.3, indicating a newer build of the entry. This change is limited to metadata; the study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    An updated revision tag from v3.6.0 to v3.6.2 appears on the page, indicating a newer version of the Study Details page. The change does not modify the study content or visible details.
    Difference
    0.1%
    Check dated 2026-06-27T00:20:37.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record now lists the investigator Wilson Miller and Jewish General Hospital as collaborators and adds new navigation elements and section labels (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading. The page revision has been updated to v3.6.0, and previously shown items such as 'Last known status was:' and 'Verified' were removed along with the older 'Intervention / Treatment' label and revision tag.
    Difference
    2%
    Check dated 2026-06-12T13:41:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous Revision: v3.5.4. This reflects a page version update without altering the study details or user workflow.
    Difference
    0.1%
    Check dated 2026-06-05T09:52:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a software/backend update. No visible study details or eligibility criteria appear to be changed.
    Difference
    0.1%
    Check dated 2026-05-14T23:15:26.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added and the previous v3.5.2 tag removed, signaling an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-04-30T16:27:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.